Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2026-01-31 @ 6:34 AM
Study NCT ID:
NCT02906150
Status:
UNKNOWN
Last Update Posted:
2016-09-19
First Post:
2016-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
Sponsor:
SciClone Pharmaceuticals
Organization: